Stock Price Quote

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC
BSE28780.70177.85 (+0.62 %)
PREV CLOSE ( ) 28602.85
OPEN PRICE ( ) 28596.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1483
TODAY'S LOW / HIGH ( )28596.50 28900.00
52 WK LOW / HIGH ( )21907.45 29628.15
NSE28795.65206.55 (+0.72 %)
PREV CLOSE( ) 28589.10
OPEN PRICE ( ) 28739.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 28795.65 (13)
VOLUME 11877
TODAY'S LOW / HIGH( ) 28600.00 28924.00
52 WK LOW / HIGH ( )22000 29638.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-08 1944
Management Info
Munir Shaikh - Chairman Swati Dalal - Managing Director
Registered Office

Address Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone 022-50461000 / 2000 / 67978888

Email webmasterindia@abbott.com / investorrelations.india@abbott.com

Website www.abbott.co.in

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

11Jun Abbott India informs about resignation
Abbott India has informed that Sabina Ewing (DIN: 09201770), has tendere..
09May Appointment of Statutory Auditors
Inter alia, approved:- 1. The Board of Directors re comm ended payment..
12Apr Abbott India informs about appointment
In compliance with Regulation 30 of the Securities and Exchange Board of..
27Mar Abbott India informs about newspaper a
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
19Mar Abbott India informs about resignation
With reference to its earlier communication dated December 19, 2023, whe..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit2870.612012.2
Gross Profit 3896.8 16177.5
Operating Profit 4106.817013.7
Net Sales 14386.358489.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE)
peergroup  3053.90 (2.71%)
M.Cap ( in Cr)103357.85
Pfizer (BSE)
peergroup  5088.35 (1.60%)
M.Cap ( in Cr)23278.05
Ajanta Pharma (BSE)
peergroup  2284.45 (2.76%)
M.Cap ( in Cr)28529.99
Innova Captab (BSE)
peergroup  558.10 (8.38%)
M.Cap ( in Cr)3193.72
Bharat Parenterals (BSE)
peergroup  1515.00 (1.86%)
M.Cap ( in Cr)988.45

Shareholding Pattern

PROMOTERS 74.99%
MUTUAL FUNDS/UTI 7.59%
NON-INSTITUTION 16.02%
FI/BANKS/INSURANCE 1.12%
GOVERNMENT 0%
FII 0%

About Abbott India Ltd.

Abbott India Ltd. was incorporated in the year 1944. Its today's share price is 28780.7. Its current market capitalisation stands at Rs 61156.98 Cr. In the latest quarter, company has reported Gross Sales of Rs. 60435.7 Cr and Total Income of Rs.60972.3 Cr. The company's management includes Sangeeta Shetty, Sabina Ewing, Mahadeo Karnik, Ambati Venu, Kaiyomarz Marfatia, Shalini Kamath, Munir Shaikh, Anisha Motwani, Swati Dalal, Sudarshan Jain.

It is listed on the BSE with a BSE Code of 500488 , NSE with an NSE Symbol of ABBOTINDIA and ISIN of INE358A01014. It's Registered office is at Unit No. 3,Corporate Park,Sion Trombay RoadMumbai-400071, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells LLP, Deloittee Haskins & Sells, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.